RICKELL GORDON: Open Payments
NPI 1093132052 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 67 payments from 9 companies in 2025. Trend: 2023 $1,361 · 2024 $1,140 · 2025 $2,291
Food & beverage: $2,291
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $736 |
| Novo Nordisk Inc | 18 | $582 |
| ABBVIE INC. | 8 | $333 |
| Exact Sciences Corporation | 10 | $197 |
| AstraZeneca Pharmaceuticals LP | 3 | $165 |
| SANOFI-AVENTIS U.S. LLC | 1 | $109 |
| PFIZER INC. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $49 |
Products named: OTEZLA, Ozempic, QULIPTA, REPATHA, The Cologuard Plus Collection Kit, AIRSUPRA, Wegovy, Rybelsus.
Industry payments across NY — which companies pay providers there.
